Introduction
Epstein-Barr virus (EBV) is an oncogenic virus belonging to the gamma herpes virus family and is associated with various lymphoid and epithelial malignancies (1) (2) (3) (4) . EBV is found in about ~10-20% of gastric adenocarcinomas, accounting for up to 75 000 new cases of gastric cancer per year. In gastric cancer in particular, EBV displays type I latency, which includes the limited expression of LMP2A, EBERs, EBNA1 and BARF0 genes (1) . In epithelial cells, latent membrane protein 2A (LMP2A) was shown to induce transformation, anchorage independence, promote motility and inhibit differentiation (5) , all functions that can promote malignant cell growth.
The viral LMP2A protein consists of a 119 amino acid-long tyrosine-rich N-terminal cytoplasmic tail, 12 hydrophobic membrane spanning domains containing the immunoreceptor tyrosine-based activation motif (ITAM), proline and tyrosine rich (PY) and tyrosine glutamic acid, glutamic acid alanine motif (YEEA) domains involved in the modulation of intracellular signaling pathways (5, 6) and a short 27 amino acid C-terminal cytoplasmic tail and forms aggregates in patches on the surfaces of latently infected cell. LMP2A activates the phosphatidylinositol 3-kinase PI3-kinase and serine/threonine kinase Akt signaling pathway, which has a pivotal role in cell proliferation, epithelial-mesenchymal transition (EMT), and anchorage-independent cell growth (5, 7, 8) . In addition, LMP2A inhibits transforming growth factor β1-induced apoptosis in a gastric cancer cell line (HSC-39) and has also been shown to promote extracellular signal-regulated kinase/Fra-1-mediated EMT (9) .
Significantly, LMP2A has been shown to constitutively activate the Notch pathway in epithelial cells (10) . The evolutionary conserved Notch pathway is known to regulate cell growth, differentiation and cell fate. Interaction of Notch ligand with its receptor initiates the pathway by releasing the Notch intracellular domain by proteolytic γ-secretase complex. The released Notch intracellular domain then translocates to the nucleus and modulates transcription of many downstream targets, the chief among them being transcription factors of the Hes family including Hes1, Hes5, Hey1, Hey2 and HeyL (11) .
Mitochondria are dynamic organelles, their shape and size being variable and controlled by antagonistic processes of fission and fusion (12) . Genetic and biochemical studies have identified and characterized the major components of the fusion and fission machineries: mitofusins (Mfn1/2) and optic atrophy factor (Opa1) contributing to mitochondrial fusion and dynamin-related protein 1 (Drp1) and Mitochondrial Fission 1 Protein (Fis 1) being responsible for fission (13) (14) (15) (16) . A delicate balance between these two processes is important for many physiological outcomes such as mitochondrial morphology, metabolism, apoptosis, neuronal activity, autophagy, embryonic development and lymphocyte chemotaxis. A deeper understanding of the remarkable dynamic nature of mitochondria has helped to generate a recent wave of new studies demonstrating abnormal mitochondrial dynamics in many important pathological conditions including neurodegenerative diseases, diabetes, arrhythmias and cancer (17) .
Significantly little is known about the role of virus, especially EBV in modulating mitochondrial dynamics. As stated before, expression of EBV latent protein increases their invasive/migratory ability, induces EMT (18) and stimulates stem cell side populations and the expression of stem cell markers in naso pharyngeal carcinoma (19) . In addition, our earlier report indicates that expression of both Epstein-Barr virus non-coding RNA (EBERs) and LMP2A leads to an increase in cell invasion and chemoresistance in EBV negative gastric cancer cell (20) . Mitochondria, especially mitochondrial dynamics, is required for various cellular functions and recently breast cancer migration and invasion has been associated with dysregulated dynamics (21) . In this context, it would be interesting to investigate whether expression of the viral LMP2A gene has any effect in mitochondrial dynamics and hence modulate cellular invasive capacity of EBV-associated gastric cancer cells.
Materials and methods
Materials γ-secretase inhibitor and G418 were purchased from Calbiochem (Merck Ltd), Invitrogen (Carlsbad, CA), respectively, and dissolved in dimethyl sulfoxide. The Drp1 and Mfn1 primary antibodies were purchased from BD biosciences (San Jose, CA) and Abcam (Cambridge, UK), respectively, whereas β-actin antibody, anti-rabbit and anti-mouse horseradish peroxidase-conjugated secondary antibodies were purchased from Cell Signaling Technology (Beverly, MA). Snail, Slug, Vimentin, Twist and LMP2A primary antibodies were also purchased from Abcam (Cambridge, UK).
Cell culture
Human gastric cancer cell lines, EBV negative AGS and EBV positive SNU719 (Korean Cell Line Bank) were maintained in RPMI 1640 (Gibco, Carlsbad, CA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum in 5% CO 2 humidified atmosphere at 37°C. EBV negative human breast cancer cell line, MCF7, was grown in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA). 
DNA constructs and transfection

RT-PCR and Quantitative RT-PCR
Total RNA was extracted using tripure isolation reagent (TRIZOL, Roche, Mannheim, Germany) and quality assayed using RNA gel electrophoresis and spectroscopy (Eppendorf BioPhotometer, Hamburg, Germany). Three micrograms of RNA was subsequently treated with RNAse-free DNAse (DNAfreeTM Ambion, Austin, TX) and reverse transcribed for 90 min at 42ºC using random hexamer primers and M-MuLV reverse transcriptase (Fermentas, Burlington, Ontario, Canada). Quantitative real time PCR (RT-PCR) was performed using SYBR Green core PCR reagents (Applied Biosystems, Framingham, MA) and HPRT1 as the endogenous control. The qRT-PCR reactions and analyses were carried out in 7500 Sequence Detection System (Applied Biosystems). The primer sequences were as follows: (i) LMP2A; 5′-TTTTGCAGTCGCTGCTGCAG-3′ (sense primer) and 5′-TACAGATAGATGGCACTCTT-3′ (antisense primer); (ii) Drp1; 5′-GTGAGGCAGGAGAATTGCTTGA-3′ (sense) and 5′-TTGAGACGGAGT TTCGCTCTTG-3′ (antisense); (iii) Fis 1; 5′-TACCGGCTCAAG GAATACGAGA-3′ (sense primer) and 5′-TTGTCAATGAGCCGCTCCA-3′ (antisense primer); (iv) Mfn1; 5′-TGTTTTGGTCGCAAACTCTG-3′ (sense) and 5′-CTGTCTGCGTACGTCTTCCA-3′ (antisense); (v) Mfn2; 5′-ATGCATCC CCACTTAAGCAC-3′ (sense primer) and 5′-CCAGAGGGCAGAACT TTGTC-3′ (antisense primer); (vi) Opa1; 5′-CCGCTTTATGACAGA ACCGAAA-3′ (sense primer) and 5′-CCTCCGCAAAGTCATTCCACT-3′ (antisense primer); (vii) N-cadherin; 5′-ATCCTACTGGACGGTTCG-3′ (sense) and 5′-TTGGCTAATGGCACTTGA-3′ (antisense); (viii) E-cadherin; 5′-CACCCATCCTCACCCTTGA-3′ (sense) and 5′-CGTAGGGAAACTC TCTCGGT-3′ (antisense); (ix) MMP-2; 5′-GGACTGCCCCCTGATGTCCA-3′ (sense primer) and 5′-AGGTCCACGACGGCATCCTTG-3′ (antisense primer); (x) MMP-14; 5′-CATTGGAGGAGACACCCACT-3′ (sense primer) and 5′-TGGGGTTTTTGGGTTTATCA-3′ (antisense primer); (xi) Hes1; 5′-GAAGGCGGACATTCTGGAAA-3′ (sense primer) and 5′-GTTCATGCA CTCGCTGAAGC-3′ (antisense primer); (xii) Hes-5; 5′-GACCGCATCAA CAGCAGCAT-3′(sense primer) and 5′-CGCTCACCTTTGCTGTGCTT-3′ (antisense primer); (xii) Hey1; 5′-CTGCAGATGACCGTGGATCA-3′ (sense primer) and 5′-CAACTTCTGCCAGGCATTCC-3′ (antisense primer).
Western blot analysis
Cells were harvested, lysed in Nonidet P-40-lysis buffer [20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 10% glycerol, 1% Nonidt P-40, 2 mM ethylenediaminetetraacetic acid (EDTA), 200 µM Na 3 VO 4 , 100 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail (Roche, Mannheim, Germany) and phosphatase inhibitor (Roche, Mannheim, Germany)] for 30 min on ice and centrifuged at 16 000g for 5 min at 4ºC and the supernatant was collected. Equal amounts of protein (25-50 µg) were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrotransferred onto nitrocellulose membrane (GE Healthcare). The protein blot in the membrane was blocked with 5% bovine serum albumin in Tris-buffered saline (TBS) containing 0.1% Tween 20 (Sigma Chemical Co., St. Louis, MO) for 1 h at room temperature. Primary antibodies as indicated were incubated with membranes for 4ºC overnight, and the membranes were washed in TBS-T, probed with horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology, Beverly, MA) for 1 h (1:3000 dilution in TBS-T) and then washed with TBS-T. The antibody-bound protein bands were detected with enhanced chemiluminescence reagent (Amersham Biosciences, Pittsburgh, PA) and photographed using VersaDoc chemiluminescence detector and Quantity ONE software (Bio-Rad, Hercules, CA).
RNA interference
The sequence of small interfering RNA (siRNA) for inhibiting expression of LMP2A messenger RNA was identical to that previously reported (22) .
A controlled, scrambled sequence was also used (Sigma). The siRNAs were transfected using Lipofectamine 2000 (Invitrogen) into SNU719 cell line and the cells assayed for silencing at different time points using independent sets of transfection experiments.
Confocal microscopy
Cells grown to 80% confluency on glass coverslips were transfected with pAcGFP1-Mito (clontech, CA) for fluorescent labeling of mitochondria. The fluorescence from pAcGFP1-Mito expression can be seen inside the mitochondrial matrix inside the inner membrane. pAcGFP1-Mito encodes a fusion of a mitochondrial targeting sequence derived from the precursor of subunit VIII of human cytochrome C oxidase and the green fluorescent protein from Aequorea coerulescens. The mitochondrial targeting sequence is fused to the N-terminus of AcGFP1. Forty-eight hours after transfection, these cells were mounted on a slide and observed under ×63 oil immersion objective in a confocal microscope (Carl Ziess LSM 510 Meta). Mitochondrial length was estimated using Image J software (National Institute of Health) and results represented as relative change in mitochondrial length compared with controls. Mitochondria having length ≤ 0.5 μm were considered as punctuate. The percentage of punctuate mitochondria in all the above cells was calculated and represented.
Invasion assay
BioCoat Matrigel Invasion chambers (BD Biosciences, San Jose, CA) were allowed to reach room temperature. Warm (37ºC) growth medium was added to the interior of the inserts (2 ml each) and wells (2 ml each). Rehydration for 2 h in humidified culture incubator (37ºC, 5% CO 2 atmosphere) was followed by careful removal of media without disturbing the layer of Matrigel matrix. An equal number (3 × 10 5 ) of cells were resuspended in 2 ml of serum-free RPMI 1640 mediun containing 0.2% bovine serum albumin and plated on the Matrigel-coated upper surface of the filter membrane in each insert. The growth medium containing 10% fetal bovine serum was used as a chemoattractant in the bottom well. After 24 h of incubation, noninvading cells were removed from the upper surface of the membrane by scrubbing with a cotton swab. Cells that invaded into the Matrigel were migrated out onto the lower surface of the membrane. Cells on the lower surface of the membrane were then fixed in prechilled 100% methanol and stained with hematoxylin solution. Several fields of stained cells per filter were counted under a phase contrast light microscope and photographed at ×10 magnification.
Wound healing scratch assay was performed on fully confluent monolayers. A scratch or wound was introduced with the help of a 200 μl tip. Images were then acquired at 0, 10, 24 and 48 h in a phase contrast microscope under ×10 magnifications. Distances were measured using Image J software (National Institute of Health) and cell invasion was represented as percentage (%) closure of wound.
Determination of transfection efficiency by flow cytometry
The plasmids containing green fluorescent protein tag were transfected into the cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Forty-eight hours posttransfection cells were harvested by trypsinization and then resuspended in phosphate-buffered saline. These cells were subjected to flow cytometry. Number of transfected cells was determined by Cell Quest Pro software in FACS Calibur (Becton Dickinson, San Jose, CA). Ten thousand events were acquired for analysis. FL1-Log (x-axis; green florescence) versus SSC-Lin (yaxis; Side Scatter) was analyzed and displayed.
Statistical analysis
Results obtained from all experiments were reported as the mean ± SEM. The significance of the analyzed data was calculated by standard student's t-test. The gene expression levels were compared by unpaired two-tailed t-test. Only P < 0.05 was considered statistically significant.
Results
LMP2A expression is associated with increased mitochondrial fission
The LMP2A cDNA (kindly provided by Prof. R.Longnecker, Northwestern University, Chicago, IL) was cloned into the EcoR1 site of the vector pcDNA and transfected into gastric (AGS) and breast (MCF7) epithelial cancer cells to produce constitutively LMP2Aexpressing stable cell clones. The plasmid pcDNA stably transfected cells were used as vector controls. Expression of LMP2A in AGS-LMP2A clones (clone 2, 5 and 8), MCF7-LMP2A (clone 1 and 3) and also EBV positive Korean gastric cancer cell SNU719 was confirmed using RT-PCR ( Figure 1A) . The protein expression levels of LMP2A in AGS-LMP2A (clones 2, 5 and 8) and SNU719 was also estimated by immunoblotting and depicted in Supplementary  Figure 1A , available at Carcinogenesis Online. Since mitochondrial dynamics alteration has been correlated with epithelial cancers, we proceeded to determine if LMP2A may have any effect on the dynamic balance of mitochondria. Clones of AGS and MCF7 cells stably expressing LMP2A were subjected to quantitative RT-PCR to estimate the relative transcriptional levels of the key genes associated with mitochondrial dynamics. Results reveal that both the above cells show a marked upregulation of Drp1 (key player of mitochondrial fission) compared to any of the other players upon expression of LMP2A. As shown in Figure 1B , AGS-LMP2A (clone 2, clone 5 and clone 8) shows a 6.21 ± 0.4, 9.21 ± 0.48 and 8.21 ± 0.5 fold upregulation, respectively, of fission gene Drp1. Since LMP2A and EBERs are among the limited genes expressed in latency I, the relative gene expression levels of mitochondrial dynamics were also determined in AGS-EBERs and AGS-LMP2A-EBERs. Although AGS-EBERs showed no significant enhancement of mitochondrial fission genes over the fusion genes (Supplementary Figure 1B , available at Carcinogenesis Online), AGS-LMP2A-EBERs did reveal an upregulated Drp1 relative to vector control cells (Supplementary Figure 1C , available at Carcinogenesis Online), thereby establishing the fact that only LMP2A and not EBERs bring about this dynamic shift. Similarly, MCF7-LMP2A (clone 1 and 3) indicates a 9.19 ± 0.2 and 11.1 ± 0.26 fold upregulation of Drp1 ( Figure 1B) . As AGS-LMP2A (clone 5) and MCF7-LMP2A (clone 3) show similar level of expression of Drp1compared with SNU719, these clones were subsequently used in all further experiments. Alterations of mitochondrial protein levels were also estimated using immunoblotting where AGS-LMP2A (clone 5) and MCF7-LMP2A(clone 3) indicate an elevated Drp1 (2.93 ± 0.15 and 1.8 ± 0.13 fold), and a 0.64 ± 0.03 and 0.56 ± 0.08 fold downregulation in Mfn1, respectively, ( Figure 1C and 1D) . In order to further establish the role of LMP2A in elevated fission, expression of Drp1 was evaluated in EBV positive gastric cancer cells SNU719. It was observed that SNU719 manifests an elevated fission relative to EBV negative gastric cancer cells AGS ( Figure 1B and 1C ). Further confirmation of imbalance in mitochondrial dynamics was done by evaluating mitochondrial morphology in a confocal microscope. pAcGFP1-Mito (Clontech, CA) was transfected into AGS/MCF7 stably expressing either pcDNA or LMP2A, as well as in SNU719 cells. Forty-eight hours after transfection cells were mounted on a slide and observed in a confocal microscope. It was evident that LMP2Aexpressing clones of AGS and MCF7 showed a more punctuate and fragmented mitochondrial morphology compared with their respective vector controls ( Figure 1E and 1F ). SNU719 mitochondria also showed a punctate distribution of mitochondrial ( Figure 1E ). Length of mitochondria was calculated using Image J software (National Institute of Health) and results represented as relative change in mitochondrial length compared with vector control cells. The percentage of mitochondria that show puntate morphology in these cells was also analyzed as discussed in Materials and methods and represented ( Figure 1E and 1F) . Our results clearly indicate that LMP2A expression leads to alteration of the fission-fusion equilibrium, shifting the balance toward fission. To assess whether the observed elevation of Drp1 could be indeed attributable to LMP2A, we knocked down LMP2A mRNA transcripts using LMP2A siRNA in a time-dependent manner in SNU719 cells. Transfection of LMP2A siRNA caused >80% of reduction in LMP2A expression compared with scrambled siRNA (Figure 1G) , whereas a concomitant reduction in Drp1 expression in a time-dependent manner was also observed in the SNU719 cells ( Figure 1H ).
LMP2A expression induces epithelial-mesenchymal transition and cell migration
Since LMP2A has already been reported to induce cell migration in naso pharyngeal carcinoma cells, we therefore examined whether LMP2A could induce similar migration in gastric and breast cancer cells. In vitro wound healing scratch assay was performed on AGS and MCF7 cells stably expressing LMP2A and images were acquired at 0, 10, 24 and 48 h postintroduction of scratch in a phase contrast microscope. Results indicate that LMP2A significantly increases the migratory ability of gastric cancer and breast cancer cells. Figure 2A shows that although AGS control cells show 16.17 ± 1.18% migration at 48 h, AGS-LMP2A cells showed a 70.32 ± 1.9% closure of wound at the same time point. Moreover, transwell migration assay further revealed that introduction of LMP2A leads to enhanced migration potential since control AGS cell shows 77 ± 8 migrated cells/field, whereas AGS-LMP2A shows 315 ± 10 migrated cells/field on the lower surface of the membrane after 24 h ( Figure 2B) . Similarly, although MCF7 control cells show 13.85 ± 1.07% closure, MCF7-LMP2A reveals a 31.10 ± 0.19% closure of wound at 48 h ( Figure 2C ). Furthermore, quantitative real-time PCR was performed to determine the transcript level expression of some important players of EMT viz. N-Cadherin, E-Cadherin, MMP-2 and MMP-14 in AGS and MCF7 cells. Both AGS-LMP2A and MCF7-LMP2A show upregulated mesenchymal markers (N-Cadherin, MMP-2 and MMP-14) and an almost unchanged E-Cadherin (epithelial marker; Figure 2D and E). In order to further confirm increased EMT in LMP2A-expressing cells, the protein expression levels of some other prime EMT markers viz; Snail, Slug, Vimentin and Twist were also determined using immunoblotting in AGS/MCF7-LMP2A ( Figure 2F and G) and in SNU719 ( Figure 2F ), compared with their respective controls. The levels of all these markers were shown to be increased in LMP2A-expressing epithelial cells relative to their respective controls.
Increase of Drp1 upon LMP2A overexpression is responsible for enhanced cell migration
Since Drp1 has previously been associated with migration and invasion of breast cancer cells, we therefore determined if overexpressed Drp1 is responsible for the increased cell invasion and EMT observed in our cell lines. Our results clearly show that indeed upregulation of Drp1 due to LMP2A expression is one of the factors leading to enhanced cell migration because introduction of the dominant negative construct, dnDrp1 (Drp1K38A; plasmid kindly provided by Prof. A.M.van der Bliek, Department of Biological Chemistry, UCLA School of Medicine, Los Angeles, CA) hinders cell migration in AGS-LMP2A cells ( Figure 3A and B) as evidenced by scratch assay (at 0, 10, 24 and 48 h) and transwell migration assay. Transfection of dnDrp1 also decreases cell invasion in MCF7-LMP2A ( Figure 3C ) and in EBV positive gastric cancer cell SNU719 ( Figure 3D ). Transient transfection of dnDrp1 (48 h) in AGS/MCF7-LMP2A and SNU719 leads to 53.49, 63.6 and 45.9% transfection, respectively, as evidenced by flow cytometry (Supplementary Figure 2B , available at Carcinogenesis Online). Real-time PCR analysis of EMT markers revealed a downregulation of mesenchymal markers and a marked upregulation in E-Cadherin expression upon introduction of dnDrp1 in AGS-LMP2A, MCF7-LMP2A and SNU719 cells ( Figure 3E-G) . Furthermore, overexpression of wtDrp1 in AGS and MCF7 resulted in enhanced wound closure, compared with untransfected control cells ( Figure 3H and I) . In addition, AGS-Drp1 and MCF7-Drp1 displayed increased EMT gene expression relative to their respective control cells ( Figure 3J and K) . Results displayed are representation of mean ± SEM of n ≥ 3 individual experiments. Transient transfection of Drp1 (48 h) in AGS/MCF7 control cells shows 52.4 and 70.2 percent transfection, respectively, as analyzed by flow cytometry ( Supplementary  Figure 2A , available at Carcinogenesis Online). Furthermore, the effect of dnDrp1/wtDrp1 on mitochondrial morphology was estimated with the help of confocal microscopy in LMP2A-expressing cells (AGS-LMP2A, MCF7-LMP2A and SNU719) and control cells (AGS and MCF7), respectively ( Figure 3L and M) . As expected, dnDrp1 reduces punctuate morphology of mitochondria, whereas wtDrp1 increases punctuate mitochondria and decreases mitochondrial length.
LMP2A increases cell migration via the Notch pathway
In order to understand the mechanism by which LMP2A may be causing increase in mitochondrial fission and invasion, we studied the Notch pathway. Notch activation in LMP2A-expressing gastric cancer and breast cancer cells was evaluated by determining the gene expression levels of Notch downstream genes in these cells compared with their respective vector controls ( Supplementary Figure 4 , available at Carcinogenesis Online). Indeed AGS-LMP2A, MCF7-LMP2A and SNU719 cells do manifest an upregulation of Hes1, Hes5 and Hey1 ( Supplementary Figure 4 , available at Carcinogenesis Online). We further proceeded to determine whether inhibition of the Notch pathway activated in LMP2A-expressing cells regulates cell migration by using the γ-secretase inhibitor, gamma secretase inhibitor (GSI). AGS-LMP2A, MCF7-LMP2A and SNU719 were subjected to various doses of γ-secretase inhibitor (0.5, 1.0, 1.5 and 2.0 µM) and cell invasion was measured at 0, 10, 24 and 48 h. The scratch assay results along with quantitation of closure of wound with 1.0 µM GSI is represented in Figure 4A -C. It was observed that GSI markedly reduces the migratory potential of these cells. To further confirm the involvement of Notch in cell migration, dominant negative dnCBF1 was transfected in the above cells and migration assay carried out 48 h later. Transient transfection of dnCBF1 in AGS-LMP2A, MCF7-LMP2A and SNU719 showed 70.9, 69.0 and 55.8% transfection as obtained in fluorescence-activated cell sorting analysis ( Supplementary Figure 3 , available at Carcinogenesis Online). Figure 4D -F demonstrate that the rate of migration is hampered upon introduction of dnCBF1 in LMP2A-expressing gastric cancer and breast cancer cell lines. Transcript level changes of key EMT genes were also estimated in AGS-LMP2A/MCF7-LMP2A/SNU719 treated with GSI. Studies revealed that GSI resulted in decrease in mesenchymal markers and increase in epithelial marker expression ( Figure 4G-I) . Moreover, introduction of Notch downstream gene Hey1 in AGS and MCF7 cells brings about an increase in cell invasion ( Supplementary Figure 5a and b, available at Carcinogenesis Online, respectively). Data shown are a representation of n ≥ 3 experiments and only P value < 0.05 was considered statistically significant.
LMP2A-induced Notch-pathway-mediated migration is associated with Drp1 elevation
Since our previous results did clearly indicate that Drp1 is upregulated upon LMP2A expression, we proceeded further to determine the relative expression levels of Drp1 when LMP2A-expressing cells are treated with either GSI or dnCBF1 as shown in Figure 4 . Drp1 levels were estimated both at the RNA and protein levels with the help of quantitative RT-PCR and western blotting. Our experiments showed that treatment of AGS/MCF7-LMP2A/SNU719 with 1 µM GSI lead to downregulation of Drp1 RNA (0.5 ± 0.05, 0.6 ± 0.02 and 0.5 ± 0.08 folds, respectively; Figure 5A -C) and protein levels (0.3 ± 0.05, 0.12 ± 0.09 and 0.36 ± 0.05 folds, respectively; Figure 5D -F), whereas an upregulation was observed in the markers of mitochondrial fusion. Treatment with dnCBF1 also showed similar results ( Figure 5A-F) . In order to confirm that treatment with GSI/dnCBF1 does indeed inhibit the Notch pathway, the expression of Notch downstream targets were analyzed upon treatment of AGS/MCF7-LMP2A and SNU719 with GSI and dnCBF1( Figure 5G-I) . Results demonstrate a decrease in Notch targets with GSI/dnCBF1 treatment. Therefore, our data clearly indicate that LMP2A-mediated Notch pathway disturbs the fission-fusion equilibrium by elevating Drp1, which among other factors brings about enhanced cell migration that may lead to increase in metastatic potential in EBV-infected gastric cancer and breast cancer cells.
Discussion
This study addresses the role of EBV latent protein LMP2A and its downstream activated notch pathway in mitochondrial dynamics alteration and cell migration in gastric and breast cancer cells. Previous reports indicate that LMP2A expression leads to activation of the Notch pathway in epithelial cells in order to autoregulate its own expression (10); we therefore explored whether this activated Notch pathway has any role in LMP2A-induced cellular migration. Furthermore, since alterations in mitochondrial dynamics have recently been linked to various pathophysiological disorders, we therefore proceeded to find out whether LMP2A-mediated dynamic alteration has any role in cell migration. Our results revealed that LMP2A leads to increased fission and Drp1 elevation, as well as increased rate of cell invasion.
The potential role of mitochondria in tumorigenesis has recently been investigated (23) (24) (25) . Epithelial cell carcinogenesis usually shows metastatic behavior in advanced cases where cellular migration and invasion are among the hallmarks of metastasis. A recent report (21) showed that mitochondrial fission player Drp1 is involved in metastasis of epithelial cells and that adenosine triphosphate was a prerequisite for the cytoskeleton reorganization during cell migration. Mitochondria are the cellular organelles responsible for adenosine triphosphate synthesis. Previous reports highlights the fact that mutations in mitochondrial DNA lead to enhanced metastatic potential along with increase of reactive oxygen species in cell lines (26) . Furthermore, a well-established relation already exists between EBV and mitochondria since EBV-infected B cells have been shown to cause reactive oxygen species elevation (27) . Moreover, our present study clearly highlights that EBV-LMP2A leads to an alteration of mitochondrial dynamics with a significant elevation of mitochondrial fission. Increased Drp1 may then explain the observed increase metastatic behavior of EBV-associated gastric carcinomas (28) . Mitochondrial fission has previously been shown to be responsible for glycolytic reprogramming in cancer cells (29) . It is hence possible that Drp1-mediated modification of cellular energetics may be bringing about the observed migration alteration in LMP2A-expressing cells. Furthermore, another member of the herpesviridae family, pseudorabies virus, was shown to alter mitochondrial morphology with reduction on mitochondrial length upon infection (30) , shedding light on the possibility that mitochondrial dynamics may be one of the important feature of viral infection.
Our study demonstrates EBV LMP2A-regulated Notch pathway to bring about increased cell migration along with an overexpression of EMT markers in both gastric cancer and breast cancer cells. In an earlier study, LMP2A was shown to induce ITAM/Syk and AKT-dependent migration through αV-integrin membrane translocation (5) . It may be pointed out that a cross talk between the Notch and the PI3K/Akt pathway is well established (31, 32) , which thus establishes Akt as a critical effector of Notch signaling pathway. Notch regulation of mitochondria has also been formerly reported, where activation of Notch pathway was shown to increase glucose consumption and lactate production with the activation of Akt pathway in glycolysis (33) . Moreover, it has also been reported that mitochondrial dynamic players, Mfns, are required for Notch-mediated antiapoptotic effects and cell survival in epithelial cells (34) . Interestingly, several viruses including as adenovirus, human papilloma virus and simian virus 40 have been shown to activate the Notch pathway upon infection (35) . Hence, Notch may be a one of the critical pathway required for viral maintenance and function.
In conclusion, our report shows for the first time that EBV latency 1 gene LMP2A-activated Notch pathway leads to imbalance of mitochondrial fission-fusion cycle that is manifested by increased fission. This alteration and imbalance leads to elevated cell migration and metastasis in epithelial cancer cells. Cell migration and metastasis are the markers of poor prognosis in patients with advanced stages of carcinogenesis especially epithelial cancers. Therefore, it is possible that targeting the Notch pathway and Drp1 may help in generation of new avenues of cancer therapeutics. 
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